Back to 
Arrowstreet Capital, Limited Partnership
Arrowstreet Capital, Limited Partnership
VKTX
Showing 0 of 2 quarters
Position history for Arrowstreet Capital, Limited Partnership's holdings in Viking Therapeutics, Inc.
No. Arrowstreet Capital exited its VKTX (Viking Therapeutics) position in Q1 2021. Its Q4 2020 13F listed 16,300 shares worth $92,000. Arrowstreet Capital first reported VKTX in Q4 2020 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.